GR3020893T3 - Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use - Google Patents

Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use

Info

Publication number
GR3020893T3
GR3020893T3 GR960402256T GR960402256T GR3020893T3 GR 3020893 T3 GR3020893 T3 GR 3020893T3 GR 960402256 T GR960402256 T GR 960402256T GR 960402256 T GR960402256 T GR 960402256T GR 3020893 T3 GR3020893 T3 GR 3020893T3
Authority
GR
Greece
Prior art keywords
preparation
tumor activity
pyrimidine nucleoside
nucleoside derivatives
group
Prior art date
Application number
GR960402256T
Other languages
English (en)
Inventor
Masakatsu Kaneko
Hitoshi Hotoda
Tomoyuki Shibata
Tomowo Kobayashi
Yoshihiro Mitsuhashi
Akira Matsuda
Takuma Sasaki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of GR3020893T3 publication Critical patent/GR3020893T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
GR960402256T 1991-09-30 1996-08-28 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use GR3020893T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25201591 1991-09-30

Publications (1)

Publication Number Publication Date
GR3020893T3 true GR3020893T3 (en) 1996-11-30

Family

ID=17231394

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402256T GR3020893T3 (en) 1991-09-30 1996-08-28 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use

Country Status (24)

Country Link
US (1) US5691319A (el)
EP (1) EP0536936B1 (el)
JP (1) JP2569251B2 (el)
KR (1) KR100255491B1 (el)
CN (1) CN1033227C (el)
AT (1) ATE141281T1 (el)
AU (1) AU654212B2 (el)
BR (1) BR1100621A (el)
CA (1) CA2079413C (el)
CZ (1) CZ289477B6 (el)
DE (1) DE69212759T2 (el)
DK (1) DK0536936T3 (el)
ES (1) ES2093211T3 (el)
FI (1) FI105556B (el)
GR (1) GR3020893T3 (el)
HK (1) HK204296A (el)
HU (2) HU221812B1 (el)
IL (1) IL103301A (el)
MX (1) MXPA92005623A (el)
NO (1) NO179675C (el)
NZ (1) NZ244574A (el)
RU (1) RU2085557C1 (el)
TW (1) TW205042B (el)
ZA (1) ZA927474B (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
GB9515279D0 (en) 1995-07-25 1995-09-20 Norsk Hydro As Improved therapeutic agents
CN1050846C (zh) * 1995-08-03 2000-03-29 中国医学科学院医药生物技术研究所 一种抗肿瘤抗生素云南霉素及其制备方法
AU720451B2 (en) * 1997-01-24 2000-06-01 Conpharma As Gemcitabine derivatives
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
AU4430200A (en) * 1999-05-11 2000-11-21 Sankyo Company Limited Liposome preparation of fat-soluble antitumor drug
JP3748536B2 (ja) * 2001-02-09 2006-02-22 三共株式会社 ピリミジンヌクレオシド誘導体の結晶
US6908906B2 (en) 2001-02-09 2005-06-21 Sankyo Company, Limited Crystalline forms of pyrimidine nucleoside derivative
US20050014716A1 (en) * 2003-05-21 2005-01-20 Wang Jin Wei Pancreatic cancer treatment
GB0328180D0 (en) * 2003-12-04 2004-01-07 Cyclacel Ltd Combination
MY142304A (en) * 2005-01-31 2010-11-15 Taiho Pharmaceutical Co Ltd Novel pyrimidine nucleoside compound or salt thereof
GB0523041D0 (en) 2005-11-11 2005-12-21 Cyclacel Ltd Combination
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
WO2008010571A1 (fr) * 2006-07-21 2008-01-24 Taiho Pharmaceutical Co., Ltd. Composé nucléosidique de 2'cyanopyrimidine
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB0808359D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
GB2459779A (en) * 2008-05-08 2009-11-11 Cyclacel Ltd Process for the preparation of 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine
CA2725295C (en) 2008-06-09 2016-11-08 Cyclacel Limited Combination of sapacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine
EP2431376B2 (en) * 2009-05-15 2024-02-07 Delta-Fly Pharma, Inc. Novel stable crystal of 1-(2'-cyano-2'-deoxy-beta -d-arabinofuranosyl)cytosine monohydrochloride
PL2696878T3 (pl) 2011-04-14 2020-01-31 Cyclacel Limited Schemat dawkowania dla sapacytabiny i decytabiny w kombinacji do leczenia ostrej białaczki szpikowej
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
DK2794627T3 (en) 2011-12-22 2019-01-14 Alios Biopharma Inc SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGUES THEREOF
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
CN104203969B (zh) * 2012-03-28 2016-08-31 富士胶片株式会社 1-(2-脱氧-2-氟-4-硫代-β-D-***呋喃糖基)胞嘧啶的盐
WO2013171473A1 (en) 2012-05-15 2013-11-21 Cyclacel Limited Dosage regimen for sapacitabine and seliciclib
PT3236972T (pt) * 2014-12-26 2021-09-24 Univ Emory Derivados antivirais n4-hidroxicitidina
WO2017093993A1 (en) 2015-12-03 2017-06-08 Biosight Ltd. Cytarabine conjugates for cancer therapy
US12064445B2 (en) 2015-12-03 2024-08-20 Biosight Ltd. Cytarabine conjugates for cancer therapy
IL259569B2 (en) * 2015-12-03 2024-03-01 Biosight Ltd Salts of cytarabine-amino acid conjugate
WO2019081951A1 (en) 2017-10-27 2019-05-02 Cyclacel Limited DOSAGE REGIME
EP3706762A4 (en) 2017-12-07 2021-09-01 Emory University N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTIVIRAL USES IN RELATION TO IT
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法
WO2021079129A1 (en) 2019-10-24 2021-04-29 Cyclacel Limited Dosing regimen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
DE3481191D1 (de) * 1983-07-20 1990-03-08 Teijin Ltd Antineoplastisches mittel.
US4818750A (en) * 1985-09-17 1989-04-04 Burroughs Wellcome Co. Treatment of human viral infections
ZA886890B (en) * 1987-10-09 1989-05-30 Hoffmann La Roche Novel dideoxycytidine derivatives
FR2640267B2 (fr) * 1988-01-19 1992-02-14 Univ Paris Curie Procede de synthese de l'azido-3(prime)-desoxy-3(prime)-thymidine et analogues
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
FR2632442B1 (fr) * 1988-06-06 1990-09-14 Framatome Sa Dispositif de mesure de parametres dans le coeur d'un reacteur nucleaire en service
EP0348170A3 (en) * 1988-06-21 1990-12-05 Moses Nam Fong Lee Antiviral pyrimidine derivatives
FR2635778A1 (fr) * 1988-08-26 1990-03-02 Ire Celltarg Sa Nouveaux derives de la 3(prime) azido-3(prime) deoxythymidine (azt) actifs contre le virus hiv du sida
JPH0678338B2 (ja) * 1988-09-09 1994-10-05 帝人株式会社 ２′，３′−ジデオキシシチジン−２′−エン誘導体、その製造方法及びそれを有効成分とする抗レトロウイルス剤
JP2559917B2 (ja) * 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体

Also Published As

Publication number Publication date
NO923794L (no) 1993-03-31
CN1033227C (zh) 1996-11-06
FI105556B (fi) 2000-09-15
AU2602692A (en) 1993-04-01
HUT62310A (en) 1993-04-28
IL103301A (en) 1997-07-13
ZA927474B (en) 1993-07-14
AU654212B2 (en) 1994-10-27
MXPA92005623A (es) 2002-06-19
NZ244574A (en) 1994-01-26
HU211851A9 (en) 1995-12-28
TW205042B (el) 1993-05-01
ATE141281T1 (de) 1996-08-15
DK0536936T3 (da) 1997-01-13
BR1100621A (pt) 1999-12-07
CZ298592A3 (en) 1993-12-15
KR930006045A (ko) 1993-04-20
CA2079413A1 (en) 1993-03-31
JP2569251B2 (ja) 1997-01-08
KR100255491B1 (ko) 2000-05-01
JPH05194497A (ja) 1993-08-03
NO923794D0 (no) 1992-09-30
ES2093211T3 (es) 1996-12-16
IL103301A0 (en) 1993-02-21
US5691319A (en) 1997-11-25
NO179675B (no) 1996-08-19
FI924381A (fi) 1993-03-31
NO179675C (no) 1996-11-27
EP0536936A1 (en) 1993-04-14
HK204296A (en) 1996-11-15
RU2085557C1 (ru) 1997-07-27
CA2079413C (en) 2003-09-09
HU9203115D0 (en) 1992-12-28
DE69212759D1 (de) 1996-09-19
HU221812B1 (hu) 2003-01-28
CZ289477B6 (cs) 2002-01-16
CN1072686A (zh) 1993-06-02
FI924381A0 (fi) 1992-09-29
EP0536936B1 (en) 1996-08-14
DE69212759T2 (de) 1997-04-03

Similar Documents

Publication Publication Date Title
GR3020893T3 (en) Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
WO1995007918A3 (en) Pyrimidine derivatives for labeled binding partners
IL97049A0 (en) Aryl-and heteroarylethenylene derivatives,their preparation and pharmaceutical compositions containing them
SE8804609D0 (sv) Adenosine derivatives
CA2085345A1 (en) Pyrimidine nucleoside derivatives
UA27220C2 (uk) Спосіб одержання похідних 1-фенілімідазолін-2,5-діону
RU92016591A (ru) Производные пиримидин нуклеозида
EP0191496A3 (en) Triazine derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component
IN174634B (el)
PH30732A (en) Dideoxydide-hydrocarbocyclic nucleosides.
HU9200656D0 (en) Method for producing morpholinyl derivatives of doxorubicine and pharmaceutical preparatives containing said compounds
EP0806413A4 (en) 2-SUBSTITUTED VITAMIN D3 DERIVATIVES
AU1254188A (en) Disaccharide derivatives
DE69029781D1 (de) Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung
EP0335369A3 (en) New anthracycline derivatives and processes for the preparation of the same
EP0328669A4 (en) CONNECTIONS DERIVED FROM CHALCONES.
DK480389A (da) Antitumor-aktivt derivat af sf2587, fremgangsmaade til det fremstilling og anticancermiddel indeholdende stoffet
UA10018C2 (uk) 3-(2',3',4'-окси- і 4'-метоксифенілімінометил)піридини, що проявляють протипухлинну активність
TH13784EX (th) อนุพันธ์ของพิริมีดีนนิ้วคลิโอไซด์ซึ่งมีฤทธิ์ต่อ ต้านเนื้องอก, การเตรียมสารเหล่านั้นและการใช้สาร เหล่านั้น
GB8821817D0 (en) Prostaglandins of f series
AU632856B2 (en) Novel inosine/guanosine derivatives
ZA908309B (en) Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives